| Trial Name | Description |
| PET-BOOST |
Dr. David Palma A Randomized Phase II Trial to Assess the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy. |
| ASPIRE ILD NSCLC |
Dr. D. Palma Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease (ASPIRE-ILD): A Phase II Trial |
| PROACTIVE |
Dr. A Louie A Randomized Phase III Trial of Palliative Radiation of Advanced Central Lung Tumors with Intentional Avoidance of the Esophagus |
| Checkmate 577 |
Dr. Mark Vincent A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer. |
| RICT NSCLC |
Dr. S. Gaede Identification of acute radiation-induced cardiac toxicity after non-small cell lung cancer radiotherapy with advanced multi-modality imaging |
| BR.31 Lung |
Dr. Sara Kuruvilla A Phase III Retrospective, Double-Blind, Placebo-Controlled, Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Cancer |
| RELAY - JVCY Lung |
Dr. M. Vincent A Multicentre, Randomized, Double-Blind Study of Erlotinib in Combination with Ramucirumab in Previously Untreated Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer |
| LUSTRE Lung |
Dr. Alex Louie A Randomized Trial of Medically-Inoperable Stage I Non-Small Cell Lung Cancer Patients Comparing Stereotactic Body Radiotherapy Versus Conventional Radiotherapy |
| IND.227 |
Dr. Mark Vincent A Phase II Randomized Study of Pembrolizumab in Patients with Advanced Malignant Pleural Mesothelioma. |
| MISSILE NSCLC |
Dr. D. Palma A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy plus Surgery in Early Non-Small Cell Lung Cancer |
| STOP-NSCLC |
Dr. David Palma Sterotactic Radiotherapy for Oligo-Progressive Non-Small Cell Lung Cancer |
| NRG-LU002 |
Dr. Alex Louie Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial. |
| SUNSET |
Dr. David Palma SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial. |
| B-FAST NSCLC |
Dr. M. Vincent A phase II/III multicenter study evaluating the efficacy and safety of multiple targeted therapies as treatments for patients with advanced or metastatic non-small cell lung cancer (NSCLC) harboring actionable somatic mutations detected in b |
This information is updated by the Clinical Research Unit
